Company Overview
Snapshot
Founded in August 2012 by Omri 'Bob' Shor, Dudi Klein, and Rotem Shor, Medisafe operates with 51–200 employees. The company has successfully raised $51.5 million across 7 funding rounds, with Pitango HealthTech participating as an investor in multiple rounds. In February 2022, Medisafe launched its Digital Document Exchange module, significantly streamlining medication approval processes.
Business overview
Medisafe provides a personalized medication management platform designed to help patients adhere to their prescribed regimens. The platform connects users with family for support, delivers custom notifications for appointments and refills, offers medication updates, personalized health recommendations, and discounts. It also tracks progress correlated with biometric data like blood pressure and glucose levels to demonstrate the direct health benefits of adherence. Medisafe aims to improve patient satisfaction and quality of care while reducing hospital admissions and outpatient visits caused by incorrect or missed doses. The company serves patients, healthcare providers, and payers, operating within the Digital Healthcare, Patient Engagement, and Pharmaceuticals sectors, leveraging mobile and AI technologies.
Strategic signal
In February 2022, Medisafe introduced its Digital Document Exchange module, a significant enhancement that allows patients to upload and submit required documentation directly through the app. This innovation dramatically reduces medication approval times from an average of 24 days to 10 minutes, improving connectivity and interoperability among care teams and patient support services. This development signals Medisafe's ongoing commitment to streamlining administrative burdens, enhancing patient engagement, and building a more efficient model for patient support within the digital therapeutics landscape.
Log in to access full profile ›Company Intelligence Q&A
- What significant product enhancement did Medisafe launch in early 2022?
- In February 2022, Medisafe launched its Digital Document Exchange module, enabling patients to upload and submit required documentation directly via the app, reducing medication approval times from an average of 24 days to 10 minutes.
- What were the key findings from Medisafe's validation studies announced in June 2021?
- In June 2021, Medisafe announced validation studies showing its digital drug companion increased persistence to specialty medications by 15% and improved adherence by 7%. Users of the Medisafe program also demonstrated 5.8% higher adherence and remained compliant for an additional five weeks compared to non-users.
- Which investors led Medisafe's Series C funding round in February 2021?
- In February 2021, Medisafe completed a $30 million Series C funding round led by Sanofi Ventures.
- What new platform did Medisafe launch in late 2020?
- In November 2020, Medisafe launched its Medisafe Maestro platform, designed to provide personalized patient support resources and real-time monitoring to orchestrate medication adherence journeys with precision and speed.